Company News

The Impact of Genetic Disorders in Vietnam 

Prevalence of Genetic Variants 

Genetic disorder testing in Vietnam has revealed startling statistics about the prevalence of certain conditions. More than 12 million Vietnamese carry the genetic variant responsible for thalassemia, a recessive blood disorder that affects red blood cells. This high number underscores the critical importance of widespread genetic screening in the country. 

Common Genetic Disorders 

Several genetic disorders are particularly prevalent in Vietnam: 

• Beta-thalassemia affects 1 in 16 Vietnamese 
• Cystic fibrosis impacts 1 in 23 individuals 
• G6PD deficiency occurs in 1 in 28 people 

These numbers highlight the urgent need for comprehensive genetic disorder testing in Vietnam to identify carriers and affected individuals early. 

Diversity of Recessive Diseases 

Research has identified 85 recessive diseases in Vietnam, with 17 of these having carrier frequencies of at least 1%. This diversity of genetic conditions emphasizes the complexity of the genetic landscape in Vietnam and the importance of advanced testing methods to detect and manage these disorders effectively. 

Early Detection of Genetic Disorders Can Be Life-Changing 

Genetic disorder testing in Vietnam has become increasingly crucial in recent years, offering hope and improved outcomes for countless families. Early detection through newborn screening can identify genetic disorders at the onset of life, allowing for prompt initiation of treatment. This timely intervention can significantly alter the course of a child's health and development. 

Preventing and Mitigating Disease Severity 

By identifying genetic diseases early, healthcare providers can implement interventions that prevent or lessen disease severity. For instance, certain metabolic disorders detected through screening can be managed with dietary modifications, preventing potentially life-threatening complications. This proactive approach to healthcare can dramatically improve a child's quality of life and long-term prognosis. 

Informed Decision-Making 

Genetic testing provides invaluable information for families, enabling them to make informed decisions about medical care and family planning. Understanding the genetic landscape can help parents prepare for potential health challenges, seek appropriate specialists, and make lifestyle adjustments to support their child's needs. Moreover, this knowledge empowers families to make educated choices about future pregnancies, contributing to overall family well-being. 

The Vital Role of the Vela Sentosa SX101 Genetic Disorder Testing System 

Revolutionizing Genetic Disorder Testing in Vietnam 

The Vela Sentosa SX101 is at the forefront of genetic disorder testing in Vietnam, offering a sophisticated solution for early detection and diagnosis. This state-of-the-art system provides automated nucleic acid extraction and PCR set-up, streamlining the testing process and enhancing accuracy. The efficiency of the Sentosa SX101 is particularly crucial in a country where timely identification of genetic disorders can be life-changing for patients and their families. 

Advanced Capabilities and FDA Approval 

Vela Diagnostics, the company behind the Sentosa SX101, has achieved a significant milestone with FDA approval for their NGS platform in HIV, HCV genotyping and resistance testing as well as oncology NGS testing such as NSCLC, Colorectal cancer, Thyroid cancer panel and HPV PCR testing. This recognition underscores the system's reliability and precision in genetic analysis. Furthermore, the Sentosa SX101 hardware has proven its versatility by supporting multiplex PCR-based tests for detecting urinary tract infections (UTIs), demonstrating its broad applicability in medical diagnostics. 

Empowering Healthcare Professionals 

By integrating the Vela Sentosa SX101 into their practices, healthcare providers in Vietnam can offer more comprehensive and accurate genetic disorder testing. This advanced technology not only improves diagnostic capabilities but also contributes to the overall enhancement of patient care and treatment planning in the realm of genetic disorders. 

Conclusion 

Early genetic disorder testing can profoundly impact lives in Vietnam, offering hope and improved outcomes for countless families. By embracing advanced technologies like the Vela Sentosa SX101, healthcare providers can detect potential issues sooner, enabling timely interventions and personalized care plans. As you consider implementing genetic screening programs, remember that the Vela Sentosa SX101 is part of the Getz Healthcare Vietnam portfolio. Our team stands ready to provide comprehensive education on the product and its installation, ensuring you can harness its full potential. By prioritizing genetic disorder testing, you play a crucial role in shaping a healthier future for Vietnam's next generation. 

Sources: 

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644705/ 
• https://www.nature.com/articles/s41598-024-57513-0 
• https://pubmed.ncbi.nlm.nih.gov/34233069/ 
• https://frontlinegenomics.com/world-of-genomics-vietnam/ 
• https://www.biorxiv.org/content/10.1101/2020.10.27.358358v1.full 
• https://medlineplus.gov/genetics/understanding/testing/benefits/ 
• https://karger.com/dmj/article/4/2/133/104480/The-Importance-of-Early-Detection-of-Genetic 
• https://www.ncbi.nlm.nih.gov/books/NBK115571/ 
• https://www.mayoclinic.org/tests-procedures/genetic-testing/about/pac-20384827 
• https://www.veladx.com/products/systems.html 
• https://academic.oup.com/jac/article/73/5/1152/4851147 
• https://www.genomeweb.com/pcrsample-prep/dx-focus-vela-diagnostics-sentosa-kras-test 
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911269/